摘要
背景:阿尔茨海默病(AD)是最普遍的疾病之一,数量迅速增加,但仍然没有药物来治疗或阻止这种疾病。先前关于香豆素的数据表明,司可苁莨素可能在AD中具有潜在的益处。 目的:评价天然来源香豆素-苄菪菪碱和翼状毒素-在AD的5xFAD小鼠模型中的治疗潜力 方法:两种化合物均以两剂给药给12个月大的小鼠,代表严重的AD病理。在小鼠实验中评估香豆素对认知的影响。使用LCMS / MS分析评估整个脑蛋白质组的变化。 结果:Morris水迷宫试验表明,更高剂量的翼状红霉素(16 mg / kg)显着改善了学习,蛋白质组分析显示,施用翼状红素后,特定蛋白质发生了显着变化。与AD高度相关的淀粉样蛋白β前体蛋白,胶质纤维酸蛋白和载脂蛋白E蛋白是较高剂量翼红素的差异表达蛋白之一。 结论:总体而言,翼状红蛋白作为AD晚期AD病理学的疾病修饰剂可进一步评估。
关键词: 阿尔茨海默病,5xFAD,司可苄菇,翼状毒素,无标记蛋白质组学,逆电流色谱。
Current Medicinal Chemistry
Title:Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer’s Disease Mouse Model
Volume: 29 Issue: 16
关键词: 阿尔茨海默病,5xFAD,司可苄菇,翼状毒素,无标记蛋白质组学,逆电流色谱。
摘要:
Background: Alzheimer’s disease (AD) is one of the most prevalent diseases with rapidly increasing numbers, but there is still no medication to treat or stop the disease. Previous data on coumarins suggests that scopoletin may have potential benefits in AD.
Objective: Evaluate the therapeutic potential of the coumarins with natural origin - scopoletin and pteryxin- in a 5xFAD mouse model of AD.
Methods: Both compounds were administered at two doses to 12-month-old mice, which represent severe AD pathology. The effects of coumarins were assessed on cognition in mouse experiments. Changes in the overall brain proteome were evaluated using LCMS/ MS analyses.
Results: The Morris water maze test implicated that a higher dose of pteryxin (16 mg/kg) significantly improved learning, and the proteome analysis showed pronounced changes of specific proteins upon pteryxin administration. The amyloid-β precursor protein, glial fibrillary acid protein, and apolipoprotein E protein which are highly associated with AD, were among the differentially expressed proteins at the higher dose of the pteryxin.
Conclusion: Overall, pteryxin may be evaluated further as a disease-modifying agent in AD pathology in the late stages of AD.
Export Options
About this article
Cite this article as:
Molecular Effects of Pteryxin and Scopoletin in the 5xFAD Alzheimer’s Disease Mouse Model, Current Medicinal Chemistry 2022; 29 (16) . https://dx.doi.org/10.2174/0929867328666210827152914
DOI https://dx.doi.org/10.2174/0929867328666210827152914 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements